HEALTHSPANStart secure intakeMetabolic Health + Weight ManagementDissolving-tablet option
A physician evaluates whether a patient-specific semaglutide and B12 dissolving tablet is appropriate for you. No medication or dose is chosen before that review.
WHO THIS EVALUATION MAY HELP
An evaluation may be useful for Nevada adults who want to discuss weight-loss medication and may have a patient-specific reason an FDA-approved option does not meet their needs. Your physician makes that determination; the ODT is not assumed.
WHAT YOUR PHYSICIAN CHECKS
FORMULATIONS + PRICING
THE MONTHLY PLAN INCLUDES
This is an evaluation, not a predetermined prescription. If your physician determines the ODT is appropriate, we confirm why it is needed, the strength, pharmacy, price, and follow-up before enrollment. Outside lab testing is separate.
WHAT TO EXPECTNO ENROLLMENT UNTIL DETAILS ARE CONFIRMED
TESTING + FOLLOW-UP
If semaglutide is prescribed, follow-up may include weight, appetite, side effects, and metabolic measures. We order tests only when the result can change the plan or help monitor treatment safely.
WHAT THE RESEARCH STUDIED
The major weight-loss outcome trial linked by IVLV studied once-weekly injectable semaglutide 2.4 mg—not this compounded semaglutide/B12 ODT. It does not establish equivalent absorption or weight-loss results for the ODT.
Review clinical evidence ↗SAFETY + WHETHER IT IS RIGHT FOR YOU
This compounded ODT is not FDA-approved. It is considered only after review of FDA-approved options, individual medical need, legal availability, pharmacy sourcing, and formulation-specific uncertainty.
Medication notice ↗Semaglutide + B12 ODT EvaluationSTART SECURELY
Begin with the secure intake. Your physician determines whether treatment is appropriate and explains the options. Submitting the form does not by itself enroll you in a monthly plan.